Patents by Inventor Yngve Sommarin

Yngve Sommarin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210247397
    Abstract: Present invention relates to novel antibodies and their use in an improved method of determining and detecting C4d.
    Type: Application
    Filed: June 5, 2019
    Publication date: August 12, 2021
    Inventors: Lisbeth WITT, Yngve SOMMARIN, Stefan CARLSÉN
  • Patent number: 9322828
    Abstract: The invention relates to monoclonal antibodies which are reactive with an epitope in the polypeptide represented by amino acid sequence 236 to 251 or 264 to 279 of the human CGA amino acid sequence. The invention further relates to the use of these monoclonal antibodies in an immunoassay for CGA, to immunoreagents comprising any of these two antibodies, and to test kits for the determination of CGA containing immunoreagents based on both of the monoclonal antibodies.
    Type: Grant
    Filed: April 28, 2011
    Date of Patent: April 26, 2016
    Assignee: Euro-Diagnostica AB
    Inventors: Mats Stridsberg, Yngve Sommarin
  • Publication number: 20130084585
    Abstract: The invention relates to monoclonal antibodies which are reactive with an epitope in the polypeptide represented by amino acid sequence 236 to 251 or 264 to 279 of the human CGA amino acid sequence. The invention further relates to the use of these monoclonal antibodies in an immunoassay for CGA, to immunoreagents comprising any of these two antibodies, and to test kits for the determination of CGA containing immunoreagents based on both of the monoclonal antibodies.
    Type: Application
    Filed: April 28, 2011
    Publication date: April 4, 2013
    Applicant: EURO-DIAGNOSTICA AB
    Inventors: Mats Stridsberg, Yngve Sommarin